Identification of symptom and functional domains that fibromyalgia patients would like to see improved: A cluster analysis

BMC Musculoskeletal Disorders

Volumn 11, Issue , 2010, Pages

  Bennett, Robert M ^a,b   Russell, Jon ^b   Cappelleri, Joseph C ^c   Bushmakin, Andrew G ^c   Zlateva, Gergana ^d   Sadosky, Alesia ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^d Analytica International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CLUSTER ANALYSIS; EMOTION; FATIGUE; FEMALE; FIBROMYALGIA; GROUP DYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDIMENSIONAL SCALING; PHYSICAL DISEASE; SOCIAL STATUS; VISUAL ANALOG SCALE; CHRONIC FATIGUE SYNDROME; COMORBIDITY; DAILY LIFE ACTIVITY; DISABILITY; EDUCATION; MIDDLE AGED; MOOD DISORDER; PAIN; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SELF EVALUATION; STATISTICAL ANALYSIS;

ACTIVITIES OF DAILY LIVING; ADULT; CLUSTER ANALYSIS; COMORBIDITY; DATA INTERPRETATION, STATISTICAL; DISABILITY EVALUATION; FATIGUE SYNDROME, CHRONIC; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; PAIN; QUALITY OF LIFE; SELF-ASSESSMENT; SELF-EVALUATION PROGRAMS;

EID: 77953941540     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-11-134     Document Type: Article

References (50)

1. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. F Wolfe HA Smythe MB Yunus RM Bennett C Bombardier DL Goldenberg P Tugwell SM Campbell M Abeles P Clark,, et al. Arthritis Rheum 1990 33 2 160 172 10.1002/art.1780330203 2306288
2. Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. RM Bennett, Mayo Clinic Proc 1999 74 385 398 10.4065/74.4.385
3. Evidence of involvement of central neural mechanisms in generating fibromyalgia pain. R Staud, Curr Rheumatol Rep 2002 4 299 305 10.1007/s11926-002-0038-5 12126581
4. Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario. The London Fibromyalgia Epidemiology Study. KP White M Speechley M Harth T Ostbye, Arthritis Rheum 1999 42 1 76 83 10.1002/1529-0131(199901)42:1<76::AID- ANR10<3.0.CO;2-G 9920017 (Pubitemid 29042573)
5. Disability and quality of life in patients with fibromyalgia. JA Verbunt DH Pernot RJ Smeets, Health Qual Life Outcomes 2008 6 8 10.1186/1477-7525-6-8 18211701
6. Characteristics and healthcare costs of patients with fibromyalgia syndrome. A Berger E Dukes S Martin J Edelsberg G Oster, Int J Clin Pract 2007 61 9 1498 1508 10.1111/j.1742-1241.2007.01480.x 17655684
7. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. DL Hoffman E Dukes, Int J Clin Pract 2008 62 1 115 126 10.1111/j.1742-1241.2007.01638.x 18039330
8. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. LA White HG Birnbaum A Kaltenboeck J Tang D Mallett RL Robinson, J Occup Environ Med 2008 50 1 13 24 10.1097/JOM.0b013e31815cff4b 18188077
9. An internet survey of 2,596 people with fibromyalgia. RM Bennett J Jones DC Turk L Matallana, BMC Musculoskelet Disord 2007 8 27 10.1186/1471-2474-8-27 17349056
10. The elusive concept of the symptom cluster. AM Barsevick, Oncol Nurs Forum 2007 34 5 971 980 10.1188/07.ONF.971-980 17878126
11. Symptom cluster research: conceptual, design, measurement, and analysis issues. AM Barsevick K Whitmer LM Nail SL Beck WN Dudley, J Pain Symptom Manage 2006 31 1 85 95 10.1016/j.jpainsymman.2005.05.015 16442485
12. Symptom clusters in acute myocardial infarction: a secondary data analysis. CJ Ryan HA DeVon R Horne KB King K Milner DK Moser JR Quinn A Rosenfeld SY Hwang JJ Zerwic, Nurs Res 2007 56 2 72 81 10.1097/01.NNR. 0000263968.01254.d6 17356437
13. Do urological symptoms cluster among women? Results from the Boston Area Community Health Survey. SA Hall A Cinar LC L ZS Kopp CG Roehrborn SA Kaplan RC Rosen, BJU Int 2008 101 10 1257 1266 10.1111/j.1464-410X.2008.07557.x 18419699 (Pubitemid 351549639)
14. Symptom clusters in incident dialysis patients: associations with clinical variables and quality of life. MS Thong S van Dijk M Noordzij EW Boeschoten RT Krediet FW Dekker AA Kaptein for the NECOSAD Study Group, Nephrol Dial Transplant 2008 24 1 225 230 10.1093/ndt/gfn449 18689791
15. Quantitative sensory testing in fibromyalgia patients and in healthy subjects: identification of subgroups. IM Hurtig RI Raak SA Kendall B Gerdle LK Wahren, Clin J Pain 2001 17 4 316 322 10.1097/00002508-200112000-00005 11783811
16. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. T Giesecke DA Williams RE Harris TR Cupps X Tian TX Tian RH Gracely DJ Clauw, Arthritis Rheum 2003 48 10 2916 2922 10.1002/art.11272 14558098
17. Health goal cognition and adjustment in women with fibromyalgia. NA Hamilton P Karoly AJ Zautra, J Behav Med 2005 28 5 455 466 10.1007/s10865-005- 9013-8 16179980
18. Heterogeneity of psychophysiological stress responses in fibromyalgia syndrome patients. K Thieme D Turk, Arthritis Res Ther 2006 8 1 9 10.1186/ar1863 16356200
19. Fibromyalgia subgroups: profiling distinct subgroups using the Fibromyalgia Impact Questionnaire. A preliminary study. JB de Souza P Goffaux N Julien S Potvin J Charest S Marchand, Rheumatol Int 2008 29 5 509 515 10.1007/s00296-008-0722-5 18820930
20. [Steps towards a symptom-based diagnosis of fibromyalgia syndrome. Symptom profiles of patients from different clinical settings.][German]. W Häuser I Akritidou E Felde S Klauenberg C Maier A Hoffmann V Köllner A Hinz, Z Rheumatol 2008 67 511 515 10.1007/s00393-008-0327-0 18830659
21. A 14-week, randomized, double-blind, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. LM Arnold IJ Russell EW Diri WR Duan JP Young U Sharma SA Martin JA Barrett G Haig, J Pain 2008 9 9 792 805 10.1016/j.jpain.2008.03.013 18524684
22. Patient perspectives on the impact of fibromyalgia. LM Arnold LJ Crofford PJ Mease SM Burgess SC Palmer L Abetz SA Martin, Patient Educ Couns 2008 73 1 114 120 10.1016/j.pec.2008.06.005 18640807
23. The magical number seven plus or minus two: some limits on our capacity for processing information. GA Miller, Psychol Rev 1956 63 2 81 97 10.1037/h0043158 13310704
24. Health measurement scales: a practical guide to their development and use. DL Streiner GR Norman, New York: Oxford University Press 3 2003
25. Logistic Regression. A Self-Learning Text. DG Kleinbaum M Klein, New York, NY: Springer-Verlag 2 2002
26. Cluster Analysis. MS Aldenderfer RK Blashfield, Newbury Park, CA: Sage Publications, Inc 1984 6329508
27. Multidimensional Scaling. ML Davison, New York, NY: John Wiley & Sons 1983
28. SAS/STAT User's Guide. Version 8.2. SAS Institute, Cary, NC: SAS Institute 2001
29. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. MB Scharf M Baumann DV Berkowitz, J Rheumatol 2003 30 1070 1074 12734908
30. Effects of sodium oxybate on sleep physiology and sleep-related symptoms in fibromyalgia. [abstract]. H Moldofsky S Alvarez-Horine, Ann Rheum Dis 2008 67 Suppl II 256 17604285
31. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. L Arnold YL Pritchett DN D'Souza DJ Goldstein S Iyengar JF Wernicke, Pain 2005 119 5 15 10.1016/j.pain.2005.06.031 16298061
32. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. IJ Russell PJ Mease TR Smith DK Kajdasz MM Wohlreich MJ Detke DJ Walker AS Chappell LM Arnold, Pain 2008 136 3 432 444 10.1016/j.pain.2008.02.024 18395345
33. Milnacipran for the treatment of fibromyalgia in adults: a 15-Week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. DJ Clauw P Mease RH Palmer M Gendreau Y Wang, Clin Ther 2008 30 11 1988 2004 10.1016/j.clinthera.2008.11.009 19108787
34. Fibromyalgia syndrome: Approach to management. IJ Russell, Prim Psychiatry 2006 13 9 76 84
35. Duloxetine and pregabalin: safe and effective for the long-term treatment of fibromyaliga? [commentary]. E Serra, Nat Clin Pract Neurol 2008 4 11 594 595 10.1038/ncpneuro0936 18852724
36. Fibromyalgia: should the treatment paradigm be monotherapy or combination pharmacotherapy? PJ Mease K Seymour, Curr Pain Headache Rep 2008 12 6 399 405 10.1007/s11916-008-0068-4 18973731
37. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. G Affleck S Urrows H Tennen P Higgins M Abeles, Pain 1996 68 2-3 363 368 10.1016/S0304-3959(96)03226-5 9121825
38. Disrupted sleep patterns and daily functioning in patients with chronic pain. LM McKracken GL Iverson, Pain Res Manag 2002 7 2 75 79 12185371
39. How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. MT Smith JA Haythornthwaite, Sleep Med Rev 2004 8 2 119 132 10.1016/S1087-0792(03)00044-3 15033151
40. Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. H Moldofsky P Scarisbrick R England H Smythe, Psychosom Med 1975 37 4 341 351 169541
41. Sleep disturbances in fibromyalgia syndrome: Relationship to pain and depression. SM Bigatti AM Hernandez TA Cronan KL Rand, Arthritis Rheum 2008 59 7 961 967 10.1002/art.23828 18576297
42. Sleep stage dynamics in fibromyalgia patients and controls. JW Burns LJ Crofford RD Chervin, Sleep Med 2008 9 6 689 696 10.1016/j.sleep.2007.10.022 18314389
43. The Prevalence and Clinical Impact of Reported Cognitive Difficulties (Fibrofog) in Patients With Rheumatic Disease With and Without Fibromyalgia. RS Katz AR Heard M Mills F Leavitt, J Clin Rheumatol 2004 10 2 53 58 10.1097/01.rhu.0000120895.20623.9f 17043464
44. Symptom clusters in fibromyalgia: potential utility in patient assessment and treatment evaluation. DN Rutledge M Mouttapa PB Wood, Nurs Res 2009 58 5 359 367 10.1097/NNR.0b013e3181b499d2 19752676
45. Characterization and consequences of pain variability in individuals with fibromyalgia. RE Harris DA Williams SA McLean A Sen M Hufford RM Gendreau RH Gracely DJ Clauw, Arthritis Rheum 2005 52 11 3670 3674 10.1002/art.21407 16258905
46. Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses. TA Ahles SA Khan MB Yunus DA Spiegel AT Masi, Am J Psychiatry 1991 148 12 1721 1726 1957937
47. Identifying the clinical domains of fibromyalgia: Contributions from clinician and patient delphi exercises. PJ Mease LM Arnold LJ Crofford DA Williams IJ Russell L Humphrey L Abetz SA Martin, Arthritis Rheum 2008 59 7 952 960 10.1002/art.23826 18576290
48. Clustering of symptoms associated with fibromyalgia in a Finnish twin cohort. R Markkula P Järvinen P Leino-Arjas M Koskenvuo E Kalso J Kaprio, Eur J Pain 2008 13 7 744 750 10.1016/j.ejpain.2008.09.007 18938094
49. Pharmacotherapy of fibromyalgia. PJ Mease EH Choy, Rheum Dis Clin North Am 2009 35 2 359 372 10.1016/j.rdc.2009.06.007 19647148
50. Toward the identification of symptom patterns in people with fibromyalgia. HD Wilson JP Robinson D Turk, Arthritis Rheum 2009 61 4 527 534 10.1002/art.24163 19333980